Home › Trials › Children

Hodgkin lymphoma

Study Examining the Effects of Using Rituximab Targeted Immune Therapy Along With Chemotherapy in Children With B-Cell Non-Hodgkin Lymphoma (a Relatively Common Cancer of Lymph Glands in Children)

Who can joinAsk the trial team

AgeAsk the trial team

Kind of studyObservational: no new treatment

What it testsWatches and records only

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Contact hospital

The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.

Tata Memorial HospitalMumbaiDirections ↗

Registry summary (technical)

A Prospective Multi-Center Study on Practice, Clinical Outcomes, and Toxicities in Children with Mature B-cell Non-Hodgkin Lymphoma Treated with Rituximab-Based Chemotherapy Regimen in India - NIL

Sponsor: Dr.Nirmalya Roy Moulik, Tata Memorial Hospital. Parel. Mumbai. Pin-400012
CTRI/2024/12/078641 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Aug 2026 · read by us 5 Nov 2026

Need help reaching the trial team? Write to us.

Tell us the city, the type of cancer and the trial number if you have one. We reply in simple words within 3 working days.

ट्रायल टीम से जुड़ने में मदद चाहिए? हमें ईमेल करें।

ట్రయల్ టీమ్‌ను సంప్రదించడానికి సహాయం కావాలా? మాకు ఈమెయిల్ చేయండి.

சோதனைக் குழுவை தொடர்பு கொள்ள உதவி வேண்டுமா? எங்களுக்கு மின்னஞ்சல் செய்யுங்கள்.